Gemtaz Infusmart 1.6gm Injection

About

Gemtaz Infusmart 1.6g Injection is used in the treatment of several types of cancer, including non-small cell lung cancer, breast cancer, pancreatic cancer, urinary bladder cancer, and ovarian cancer.

It is administered by a qualified healthcare professional as an intravenous injection. Your doctor will determine the appropriate dosage and treatment schedule based on your specific condition, which may be adjusted over time. It is crucial to follow your doctor’s instructions precisely, as incorrect dosage or misuse can lead to serious side effects. While it may take weeks or even months to notice improvement, do not discontinue the treatment without your doctor’s advice.

Common side effects include nausea, vomiting, loss of appetite, hair loss, and low platelet counts. This medication can also lower red and white blood cell levels, increasing your risk of infections. Regular blood tests are necessary to monitor blood cell counts, heart function, liver function, and uric acid levels.

Before starting treatment, inform your doctor if you have any existing heart, liver, or kidney conditions, or if you are taking medications for infections. Since this medicine may interact with other drugs, it's important to share a complete list of your current medications. Gemtaz Infusmart 1.6g Injection is not recommended during pregnancy or breastfeeding. Both men and women should use effective contraception during treatment to prevent pregnancy.

Uses

•       Non-small cell lung cancer
• Breast cancer
• Pancreatic cancer
• Urinary bladder cancer
• Ovarian cancer

Directions for use

This medicine should be administered by a doctor or nurse. Please do not attempt to self-administer it.

Side Effects

• Nausea
• Vomiting
• Loss of appetite
• Hair loss
• Low blood platelets
• Allergic reaction
• Breathlessness
• Decreased white blood cell count
• Increased liver enzymes
• Anemia (low number of red blood cells)
• Flu-like symptoms
• Blood in urine
• Skin rash

Safety Measures

Alcohol - Alcohol consumption is not recommended during treatment with Gemtaz Infusmart 1.6gm, as the medication may cause drowsiness or sleepiness. Consult your doctor for further guidance.
Pregnancy - Gemtaz Infusmart 1.6g Injection is unsafe to use during pregnancy as there is definite evidence of risk to the developing baby. However, the doctor may rarely prescribe it in some life-threatening situations if the benefits are more than the potential risks. Please consult your doctor.
Breastfeeding - Gemtaz Infusmart 1.6g Injection is unsafe to use during breastfeeding. Data suggests that the drug may cause toxicity to the baby.
Liver - Gemtaz Infusmart 1.6g Injection may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.
Kidney - There is limited information available on the use of Gemtaz Infusmart 1.6g Injection in patients with kidney disease. Please consult your doctor.Kidney function tests are advised before taking this medicine and regular monitoring is also recommended after the treatment.

Disclaimer

Med E Hub is committed to delivering reliable, expert-reviewed information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis, or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.